Company Monitoring Page for Biomarin

latest headlines for company on cafepharma

What Does The FDA's Breakthrough Designation Mean For Investors?
Seeking Alpha
Mon, 08/26/13 - 01:28 pm
Tags:
FDA, breakthrough therapies, AbbVie, Alexion, Ariad Pharmaceuticals, Biomarin, Bristol-Myers Squibb, SynaGeva BioPharma, GSK, JNJ, Merck, Novartis, Pharmacyclics, Pfizer, Vertex Pharmaceuticals, daratumumab, ibrutinib, Kalydeco, lambrolizumab, palbociclib, LDK378, SD-101, obinutuzumab, serelaxin, asfotase alfa, bimagrumab, drisapersen, sebelipase alfa
Is There Any Substance To The Buyout Rumors Surrounding BioMarin And Catalyst?
Seeking Alpha
Mon, 08/26/13 - 09:46 am
Tags:
M&A, Biomarin, Catalyst Pharmaceutical Partners
BioMarin Announces Oral Presentation of BMN 673 Most Recent Data on Breast and Ovarian Cancers at the European Cancer Congress 2013
Yahoo/GlobeNewsWire
Sat, 08/17/13 - 10:42 am
Tags:
Biomarin, BMN 673, breast cancer, ovarian cancer
2 Biotech Stocks That Could Be on Novartis' Buyout Radar
Motley Fool
Thu, 08/15/13 - 11:48 am
Tags:
Novartis, M&A, Biomarin, Incyte
Shire, Vertex, BioMarin among firms lobbying Congress to maintain orphan drug tax credit in proposed tax reform
FT.com
Mon, 07/29/13 - 01:39 pm
Tags:
Shire, Vertex Pharmaceuticals, Biomarin, orphan drugs, Orphan Drug Tax Credit
BioMarin Provides BMN 673 Program Update
Virtual Strategy
Sat, 07/27/13 - 11:25 am
Tags:
Biomarin, BMN 673, breast cancer
5 Drugmakers With a Lot on the Line Next Week
Motley Fool
Sun, 07/21/13 - 11:37 am
Tags:
Eli Lilly, InterMune, Gilead Sciences, Alexion, Biomarin
Exploding Pipeline Makes BioMarin Attractive Takeover Target
Motley Fool
Thu, 07/11/13 - 10:33 am
Tags:
Biomarin, M&A, Pfizer, Sanofi
Orphan drugmaker ViroPharma attracts takeover interest: sources
Reuters
Mon, 06/17/13 - 11:52 am
Tags:
ViroPharma, M&A, Biomarin
BioMarin's cancer drug success prompts launch of pivotal trial
Reuters
Mon, 06/3/13 - 12:34 pm
Tags:
Biomarin, BMN673, breast cancer, ovarian cancer
FDA delays review of BioMarin's Vimizim by three months
The Fly on the Wall
Thu, 05/30/13 - 11:33 am
Tags:
Vimizim, FDA, Biomarin
BioMarin Gains on Prospects for Experimental Cancer Drug
Bloomberg
Thu, 05/23/13 - 11:49 am
Tags:
Biomarin, Ewing's sarcoma, BMN-673, breast cancer, ovarian cancer, small cell lung cancer
BioMarin abstract showed impressive anti-tumor activity, says Leerink
Yahoo/Fly on the Wall
Thu, 05/16/13 - 10:28 am
Tags:
Biomarin, BMN-673, solid tumors
Orphan Drug Biotechs Do It Best
Motley Fool
Fri, 04/19/13 - 12:14 pm
Tags:
orphan drugs, Alexion, Biomarin, Vertex Pharmaceuticals
These 4 'High-Potential' Biotech Stocks Could Outperform In 2013
Seeking Alpha
Thu, 04/18/13 - 06:57 pm
Tags:
Arena Pharmaceuticals, Gilead, Biomarin, Acadia, Catalyst Pharmaceutical Partners
BioMarin submits CTA for BMN-190 for Batten disease
Yahoo/Fly on the Wall
Mon, 04/1/13 - 10:59 am
Tags:
Biomarin, BMN-190, Batten disease
BioMarin: Gains To Continue As Pipeline Progress Is Realized
Seeking Alpha
Mon, 03/25/13 - 12:15 pm
Tags:
Biomarin
BioMarin says it will continue studies of late-onset Pompe disease drug candidate BMN-701
Yahoo/AP
Wed, 03/20/13 - 12:26 pm
Tags:
Biomarin, Pompe disease, BMN-701
4 Biotech Stock Stars Losing Their Luster
TheStreet.com Stockpkr
Thu, 02/21/13 - 12:06 pm
Tags:
Celgene, Biogen Idec, Life Technologies, Biomarin
BioMarin Earnings: An Early Look
Motley Fool
Tue, 02/19/13 - 03:14 pm
Tags:
earnings, Biomarin

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.